RecruitingNCT05741697

HFNC in Management of Bronchiectasis Exacerbation

High Flow Nasal Cannula Versus Non-invasive Ventilation in Managing Acute Exacerbation of Bronchiectasis Patients


Sponsor

Assiut University

Enrollment

20 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Patients with Bronchiectasis experience exacerbations with hypercapnic respiratory failure associated with an increased respiratory workload that may require intensive care unit (ICU) admission due to the inability of the respiratory muscles to compensate for increased demand. These exacerbations are frequently treated with noninvasive ventilation (NIV).


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

  • Patients will be eligible for enrolment if diagnosed with bronchiectasis and admitted to the respiratory intensive care unit (RICU), requiring ventilator support without invasive mechanical ventilation.

Exclusion Criteria1

  • Age: less than 18 years. Patients with post-arrest encephalopathy. Patient with the previous tracheotomy. Patients who received invasive ventilatory support. Patients with end-organ failure.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGbi-level ventillation

non-invasive mechanical ventilation


Locations(1)

Assiut University-Faculty of medicine

Asyut, Asyut Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05741697


Related Trials